Literature DB >> 20697394

Drugmakers dance with autism.

Sarah Webb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697394     DOI: 10.1038/nbt0810-772

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.

Authors:  Simone Berkel; Christian R Marshall; Birgit Weiss; Jennifer Howe; Ralph Roeth; Ute Moog; Volker Endris; Wendy Roberts; Peter Szatmari; Dalila Pinto; Michael Bonin; Angelika Riess; Hartmut Engels; Rolf Sprengel; Stephen W Scherer; Gudrun A Rappold
Journal:  Nat Genet       Date:  2010-05-16       Impact factor: 38.330

2.  Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.

Authors:  Elissar Andari; Jean-René Duhamel; Tiziana Zalla; Evelyn Herbrecht; Marion Leboyer; Angela Sirigu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

3.  Reversal of neurological defects in a mouse model of Rett syndrome.

Authors:  Jacky Guy; Jian Gan; Jim Selfridge; Stuart Cobb; Adrian Bird
Journal:  Science       Date:  2007-02-08       Impact factor: 47.728

4.  Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.

Authors:  Robert H Ring; Lee E Schechter; Sarah K Leonard; Jason M Dwyer; Brian J Platt; Radka Graf; Steven Grauer; Claudine Pulicicchio; Lynn Resnick; Zia Rahman; Stacey J Sukoff Rizzo; Bin Luo; Chad E Beyer; Sheree F Logue; Karen L Marquis; Zoë A Hughes; Sharon Rosenzweig-Lipson
Journal:  Neuropharmacology       Date:  2009-07-15       Impact factor: 5.250

5.  Correction of fragile X syndrome in mice.

Authors:  Gül Dölen; Emily Osterweil; B S Shankaranarayana Rao; Gordon B Smith; Benjamin D Auerbach; Sumantra Chattarji; Mark F Bear
Journal:  Neuron       Date:  2007-12-20       Impact factor: 17.173

6.  Functional impact of global rare copy number variation in autism spectrum disorders.

Authors:  Dalila Pinto; Alistair T Pagnamenta; Lambertus Klei; Richard Anney; Daniele Merico; Regina Regan; Judith Conroy; Tiago R Magalhaes; Catarina Correia; Brett S Abrahams; Joana Almeida; Elena Bacchelli; Gary D Bader; Anthony J Bailey; Gillian Baird; Agatino Battaglia; Tom Berney; Nadia Bolshakova; Sven Bölte; Patrick F Bolton; Thomas Bourgeron; Sean Brennan; Jessica Brian; Susan E Bryson; Andrew R Carson; Guillermo Casallo; Jillian Casey; Brian H Y Chung; Lynne Cochrane; Christina Corsello; Emily L Crawford; Andrew Crossett; Cheryl Cytrynbaum; Geraldine Dawson; Maretha de Jonge; Richard Delorme; Irene Drmic; Eftichia Duketis; Frederico Duque; Annette Estes; Penny Farrar; Bridget A Fernandez; Susan E Folstein; Eric Fombonne; Christine M Freitag; John Gilbert; Christopher Gillberg; Joseph T Glessner; Jeremy Goldberg; Andrew Green; Jonathan Green; Stephen J Guter; Hakon Hakonarson; Elizabeth A Heron; Matthew Hill; Richard Holt; Jennifer L Howe; Gillian Hughes; Vanessa Hus; Roberta Igliozzi; Cecilia Kim; Sabine M Klauck; Alexander Kolevzon; Olena Korvatska; Vlad Kustanovich; Clara M Lajonchere; Janine A Lamb; Magdalena Laskawiec; Marion Leboyer; Ann Le Couteur; Bennett L Leventhal; Anath C Lionel; Xiao-Qing Liu; Catherine Lord; Linda Lotspeich; Sabata C Lund; Elena Maestrini; William Mahoney; Carine Mantoulan; Christian R Marshall; Helen McConachie; Christopher J McDougle; Jane McGrath; William M McMahon; Alison Merikangas; Ohsuke Migita; Nancy J Minshew; Ghazala K Mirza; Jeff Munson; Stanley F Nelson; Carolyn Noakes; Abdul Noor; Gudrun Nygren; Guiomar Oliveira; Katerina Papanikolaou; Jeremy R Parr; Barbara Parrini; Tara Paton; Andrew Pickles; Marion Pilorge; Joseph Piven; Chris P Ponting; David J Posey; Annemarie Poustka; Fritz Poustka; Aparna Prasad; Jiannis Ragoussis; Katy Renshaw; Jessica Rickaby; Wendy Roberts; Kathryn Roeder; Bernadette Roge; Michael L Rutter; Laura J Bierut; John P Rice; Jeff Salt; Katherine Sansom; Daisuke Sato; Ricardo Segurado; Ana F Sequeira; Lili Senman; Naisha Shah; Val C Sheffield; Latha Soorya; Inês Sousa; Olaf Stein; Nuala Sykes; Vera Stoppioni; Christina Strawbridge; Raffaella Tancredi; Katherine Tansey; Bhooma Thiruvahindrapduram; Ann P Thompson; Susanne Thomson; Ana Tryfon; John Tsiantis; Herman Van Engeland; John B Vincent; Fred Volkmar; Simon Wallace; Kai Wang; Zhouzhi Wang; Thomas H Wassink; Caleb Webber; Rosanna Weksberg; Kirsty Wing; Kerstin Wittemeyer; Shawn Wood; Jing Wu; Brian L Yaspan; Danielle Zurawiecki; Lonnie Zwaigenbaum; Joseph D Buxbaum; Rita M Cantor; Edwin H Cook; Hilary Coon; Michael L Cuccaro; Bernie Devlin; Sean Ennis; Louise Gallagher; Daniel H Geschwind; Michael Gill; Jonathan L Haines; Joachim Hallmayer; Judith Miller; Anthony P Monaco; John I Nurnberger; Andrew D Paterson; Margaret A Pericak-Vance; Gerard D Schellenberg; Peter Szatmari; Astrid M Vicente; Veronica J Vieland; Ellen M Wijsman; Stephen W Scherer; James S Sutcliffe; Catalina Betancur
Journal:  Nature       Date:  2010-06-09       Impact factor: 49.962

  6 in total
  13 in total

1.  Parents' perspectives on participating in genetic research in autism.

Authors:  Magan Trottier; Wendy Roberts; Irene Drmic; Stephen W Scherer; Rosanna Weksberg; Cheryl Cytrynbaum; David Chitayat; Cheryl Shuman; Fiona A Miller
Journal:  J Autism Dev Disord       Date:  2013-03

Review 2.  Risk factors for autism: translating genomic discoveries into diagnostics.

Authors:  Stephen W Scherer; Geraldine Dawson
Journal:  Hum Genet       Date:  2011-06-24       Impact factor: 4.132

3.  Is 'bench-to-bedside' realistic for autism? An integrative neuroscience approach.

Authors:  Melissa D Bauman; Cynthia M Schumann
Journal:  Neuropsychiatry (London)       Date:  2013-04

4.  Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.

Authors:  Sarah L Logan; Laura Carpenter; R Scott Leslie; Kelly S Hunt; Elizabeth Garrett-Mayer; Jane Charles; Joyce S Nicholas
Journal:  J Autism Dev Disord       Date:  2014-11

Review 5.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

Review 6.  Functional neuroimaging of treatment effects in psychiatry: methodological challenges and recommendations.

Authors:  Gabriel S Dichter; Linmarie Sikich; Allen Song; James Voyvodic; James W Bodfish
Journal:  Int J Neurosci       Date:  2012-04-30       Impact factor: 2.292

7.  A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

Authors:  Karen J Parker; Ozge Oztan; Robin A Libove; Noreen Mohsin; Debra S Karhson; Raena D Sumiyoshi; Jacqueline E Summers; Kyle E Hinman; Kara S Motonaga; Jennifer M Phillips; Dean S Carson; Lawrence K Fung; Joseph P Garner; Antonio Y Hardan
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

8.  Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology.

Authors:  Simone Berkel; Wannan Tang; Mario Treviño; Miriam Vogt; Horst Andreas Obenhaus; Peter Gass; Stephen Wayne Scherer; Rolf Sprengel; Gerhard Schratt; Gudrun Anna Rappold
Journal:  Hum Mol Genet       Date:  2011-10-12       Impact factor: 6.150

9.  Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism.

Authors:  Dean S Carson; Joseph P Garner; Shellie A Hyde; Robin A Libove; Sean W Berquist; Kirsten B Hornbeak; Lisa P Jackson; Raena D Sumiyoshi; Christopher L Howerton; Sadie L Hannah; Sonia Partap; Jennifer M Phillips; Antonio Y Hardan; Karen J Parker
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

Review 10.  Atypical antipsychotics in the treatment of early-onset schizophrenia.

Authors:  Michal Hrdlicka; Iva Dudova
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-01       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.